It may be plausible to speculate that during Western diet feeding or the development of MASLD, the liver reduces CES3 expression in order to prevent lipid accumulation, but such a reduction is insufficient to overcome the development of MASLD caused by overall metabolic changes in this process. This evidence concerns the gene CES3 and metabolic dysfunction-associated steatotic liver disease.